Table of Contents Table of Contents
Previous Page  4 / 8 Next Page
Information
Show Menu
Previous Page 4 / 8 Next Page
Page Background

Neuroscience Congress 2019

Journal of Neurology and Neurorehabilitation Research | Volume 4

Page 22

April 11-12, 2019 | Barcelona, Spain

NEUROSCIENCE AND

NEUROLOGICAL DISORDERS

2

nd

International Conference on

OF EXCELLENCE

IN INTERNATIONAL

MEETINGS

alliedacademies.com

YEARS

LITHIUM UTILIZES HIDDEN CELLULAR

‘FAIL-SAFE-MECHANISMS’

A

new unified model for Lithium’s mode of therapeutic action has re-

cently been proposed.

Lithium’s many protective actions provide evidence for the existence of

a set of low-cell [Mg++] sensitive, cell-protection systems. To survive in

conditions associated with a very low cell [Mg++], (neuronal) cells will re-

quire‘Fail-Safe’mechanisms, as below a critically low intracellular [Mg++],

many Mg++ requiring systems risk grinding to a halt. This latent vulner-

ability implies the existence of specific protective responses, activated

by a low-intracellular [Mg++], at times, (particularly post head- injury),

and used as a metabolic ‘alarm-signal’. These ‘fail-safe’systems would also

help regulate, buffer, and restore cell [Mg++], and as Li+mimics a low cell

[Mg++] level, activating these pre-existing systems provides the underly-

ing basis of Lithium’s therapeutic effects.

The ‘fail-safe’-model postulates the existence of pre-programmed bio-

chemical responses, adapted to provide protection against t.b.i., mechan-

ical brain injury; involving the activation of pathways sensitive to a low-

free cell [Mg++], these appear to be ‘parasitically’ utilised by Lithium to

generate its therapeutic effects. These systems would underpin neuronal

cell protection, and provide a key biochemical mechanism for stabilising

mood, and providing intrinsic mental and cellular resilience.

Arthur Ernst van Woerkom, J Neurol Neurorehabil Res 2019, Volume 4

Arthur Ernst van Woerkom is a general adult

psychiatrist. Completed his training in natural

sciences for medicine at Trinity Hall, and Ad-

denbrookes, Cambridge), and he have a long

standing interest in the biochemistry of mood

disorders, schizophrenia and psychosis. Many

years ago, before he started working in the field

of psychiatry, he proposed that major hallucino-

gens such as LSD and mescaline act in key part

by disrupting the fine structure of consciousness

by causing the collapse of tubulin and actin relat-

ed cytoskeletal mechanisms.

For a few years he was in an NHS funded research

fellowship at the department of psychiatry with

Prof Martin Roth. For a time, he was an honory se-

nior clinical lecturer in psychiatry in Birmingham.

ernie.vanwoerkom@nhs.net

Arthur Ernst vanWoerkom

South Birmingham & Solihull Mental Health NHS Foundation Trust, UK

BIOGRAPHY